Marcus Corporation (MCS): Primed for a Comeback
As the entertainment sector continues to recover from the pandemic's impacts, Marcus Corporation stands...
AbbVie (ABBV): A Resilient Dividend Pick Despite Patent Challenges
AbbVie's Humira Faces Challenges, but New Treatments and Dividends Shine
AbbVie, a seasoned...